Serial 98588346
Live / Allowed — First extension granted (statement of use) (as of 27 Jul 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 06 Jun 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98588346
- Mark type
- Design / logo
- Filed
- 06 Jun 2024
- Published for opposition
- 02 Dec 2025
- Attorney of record
- Joyce M. Ferraro
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for use in the treatment of oncological, cardiological, dermatological, neurological, genetic, orthopedic and metabolic diseases and disorders
Owner
- Bridgebio Pharma, Inc., Palo Alto, CA, US
- Bridgebio Pharma, Inc., Palo Alto, CA, US
Prosecution history
- 15 Sept 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 15 Sept 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 15 Sept 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 15 Sept 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 15 Sept 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 28 Jul 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Jul 2026 — SOU EXTENSION 1 GRANTED
- 27 Jul 2026 — SOU EXTENSION 1 FILED
- 27 Jul 2026 — SOU TEAS EXTENSION RECEIVED
- 27 Jan 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 02 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Dec 2025 — PUBLISHED FOR OPPOSITION
- 26 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 Nov 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 28 Mar 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED